Veritas Farms Inc (VFRM)
0.0179
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
Veritas Farms Enterprise Value: 6.821M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 6.821M |
| May 30, 2024 | 6.821M |
| May 29, 2024 | 6.821M |
| May 28, 2024 | 6.821M |
| May 24, 2024 | 6.821M |
| May 23, 2024 | 6.821M |
| May 22, 2024 | 6.821M |
| May 21, 2024 | 6.690M |
| May 20, 2024 | 6.690M |
| May 17, 2024 | 6.837M |
| May 16, 2024 | 6.837M |
| May 15, 2024 | 6.018M |
| May 14, 2024 | 6.674M |
| May 13, 2024 | 6.674M |
| May 10, 2024 | 6.674M |
| May 09, 2024 | 6.674M |
| May 08, 2024 | 6.674M |
| May 07, 2024 | 6.674M |
| May 06, 2024 | 6.819M |
| May 03, 2024 | 6.819M |
| May 02, 2024 | 6.819M |
| May 01, 2024 | 6.819M |
| April 30, 2024 | 6.505M |
| April 29, 2024 | 6.674M |
| April 26, 2024 | 6.674M |
| Date | Value |
|---|---|
| April 25, 2024 | 7.062M |
| April 24, 2024 | 7.191M |
| April 23, 2024 | 7.191M |
| April 22, 2024 | 7.191M |
| April 19, 2024 | 7.191M |
| April 18, 2024 | 7.191M |
| April 17, 2024 | 7.321M |
| April 16, 2024 | 6.854M |
| April 15, 2024 | 6.674M |
| April 12, 2024 | 6.674M |
| April 11, 2024 | 6.674M |
| April 10, 2024 | 7.321M |
| April 09, 2024 | 6.674M |
| April 08, 2024 | 6.854M |
| April 05, 2024 | 6.854M |
| April 04, 2024 | 7.286M |
| April 03, 2024 | 7.583M |
| April 02, 2024 | 7.583M |
| April 01, 2024 | 7.583M |
| March 28, 2024 | 7.583M |
| March 27, 2024 | 8.132M |
| March 26, 2024 | 8.132M |
| March 25, 2024 | 6.739M |
| March 22, 2024 | 8.312M |
| March 21, 2024 | 8.312M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
2.299M
Minimum
Nov 30 2021
265.84M
Maximum
Aug 02 2019
22.31M
Average
7.706M
Median
Feb 01 2024
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 4.387M |
| Palatin Technologies Inc | 19.03M |
| iBio Inc | 28.91M |
| Theriva Biologics Inc | -10.98M |
| Oragenics Inc | 8.699M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.135M |
| Revenue (Quarterly) | 0.2359M |
| Total Expenses (Quarterly) | 1.076M |
| EPS Diluted (Quarterly) | -0.01 |
| Gross Profit Margin (Quarterly) | 22.34% |
| Profit Margin (Quarterly) | -481.0% |
| Earnings Yield | -726.3% |
| Normalized Earnings Yield | -725.89 |